Buy Dabur India, target Rs 282.0 : Reliance Securities
Buy Dabur India Ltd. at a price target of Rs 282.0 and a stop loss at Rs 271.0 from entry point
Dabur India Ltd., incorporated in the year 1975, is a largecap company with a market cap of ₹ 48802.93 crore operating in Personal Care sector.
Dabur India Ltd. key Products/Revenue Segments include Personal Care which contributed ₹ 3051.69 Cr to Sales Value (53.07 % of Total Sales), Health Care which contributed ₹ 1572.08 Cr to Sales Value (27.34 % of Total Sales), Beverages which contributed ₹ 983.18 Cr to Sales Value (17.09 % of Total Sales), Others which contributed ₹ 132.68 Cr to Sales Value (2.30 % of Total Sales), Scrap which contributed ₹ 7.91 Cr to Sales Value (0.13 % of Total Sales), Subsidy which contributed ₹ 2.24 Cr to Sales Value (0.03 % of Total Sales), Other Operating Revenue which contributed ₹ .15 Cr to Sales Value (0.00 % of Total Sales), Sale of services which contributed ₹ .07 Cr to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2016.
For the quarter ended 31-03-2017, the company has reported a Consolidated sales of ₹ 1914.68 Cr., up 3.63% from last quarter Sales of ₹ 1847.67 Cr. and down -3.30% from last year same quarter Sales of ₹ 1980.02 Cr. Company has reported net profit after tax of ₹ 333.73 Cr. in latest quarter. The company’s CEO is Mr.Sunil Duggal. It's Board of Directors include Dr.Ajay Dua, Dr.Anand C Burman, Dr.S Narayan, Mr.A K Jain, Mr.Amit Burman, Mr.Lalit Malik, Mr.Mohit Burman, Mr.P D Narang, Mr.P N Vijay, Mr.R C Bhargava, Mr.Saket Burman, Mr.Sanjay Kumar Bhattacharyya, Mr.Sunil Duggal, Ms.Falguni Sanjay Nayar, Mr.A K Jain. Company has its registered office at 8/3, Asaf Ali Road, New Delhi, 110002, Delhi. Company has Walker Chandiok & Co. LLP as its auditors. As on 31-03-2017, the company has a total of 1,761,520,510 shares outstanding.
Download ET Markets APP